Brain Cancer Research – Dr. Robert Lieberson

Dr. Robert Lieberson

June 10, 2022

Brain Cancer Research - Dr. Robert Lieberson

According to Dr. Robert Lieberson, as the body of knowledge about brain tumors increases, so has the scope of brain cancer research. In recent years, research into brain tumors has grown significantly. We speak to David Arons, CEO of the National Brain Tumor Society. Personalized brain tumor therapy is one such area of research that may be the next breakthrough. Other areas of research to keep an eye on include Biomarker tests, Treatment options, and funding opportunities. Read on for more information.

Personalized brain tumor therapy

Personalized brain tumor therapy research is critical for a number of reasons. Using the patient’s unique DNA and tumor proteins to determine the effectiveness of a particular drug or combination of drugs, researchers can better understand the underlying biological and molecular mechanisms of brain tumor development. As this knowledge expands, personalized medicine is possible.

A recent study used a drug library to screen patient-derived xenografts against several drugs. The actinomycin D drug was found to have a strong anti-proliferative effect, extending the mice’s life span. The study suggests that this drug may have a better therapeutic potential than the standard-of-care chemotherapies, which have potentially serious side effects.

Biomarker tests by Dr. Robert Lieberson

Dr. Robert Lieberson pointed out that, the use of biomarker tests for brain cancer is gaining ground thanks to the new findings in molecular biology. New discoveries in brain tumour cells have prompted researchers to look for other possible biomarkers. Researchers are already exploring the role of several genes and mutations in the development of brain cancer. In the meantime, patients can request a free Information Pack from their neuro-oncologists.

Brain tumor tissue is usually examined using standard pathology procedures. In addition, pioneering tests are also performed to identify tumor characteristics. Such as magnetic resonance spectroscopy, for instance, measures. And aslo such as biochemical changes in the brain. Certainly this biomarker helps doctors determine. Conversely the tumor has metastasized or is in the early stages of progression.

Treatment options – Dr. Robert Lieberson

Brain tumor research is focused on prevention and treatment. Also they will also study new drugs. Listed below are some treatment options for brain tumors. Read about them to make an informed decision about your care. But before you decide, know more about each one. You should discuss the best course of action with your doctor and family.

Immunotherapy is a form of treatment that uses the body’s own immune system to fight the tumor. It uses materials produced in the body or in the lab to boost the immune system’s response to the tumor. This type of therapy involves the use of dendritic cells, vaccines against tumor surface molecules, or immunotherapy drugs. Simultaneously several types of immunotherapy are currently in clinical trials. Correspondingly oncolytic virus therapy is another brain tumor treatmen. Unquestionably uses a virus to destroy tumor cells.

Funding opportunities

Dr. Robert Lieberson described that, there are several funding opportunities available to researchers studying the biology of brain tumors, including the ABTA Research Collaboration Grants. The fund supports collaborative research initiatives aimed at identifying clinical biomarkers for brain tumors.

There are several grants available to researchers with a passion for the field. The BRIDGE Fund supports groundbreaking scientific advances at UMass Medical School. The Translational Pilot Grant for Cancer Research is available to support the translational and applied R&D efforts of collaborative research teams from UMass Amherst and UMass Medical School. Moreover the LCRF also offers seed money to investigators whose project. Involves a new drug or device development.